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Abstract
Diagnostic bacteriology has changed little over the past 50 years. Those changes that have occurred have been gradual but not funda-
mental. KIESTRA Lab Automation is a company specializing in total laboratory automation (TLA). Their methodology incorporates plate
labelling and delivery, inoculation and spreading, incubation and digital image analysis. This has led to a paradigm shift in processing since
decisions are made from images on a computer screen rather than examination of the actual plates. The result is the development of a
skill mix based on the requirements of the service. This allows for the development of a lean and highly efficient laboratory.
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KIESTRA Lab Automation is a company specializing in total
laboratory automation (TLA) for the bacteriology laboratory.
The company initially marketed its automation solutions for
plate movements and incubation to laboratories in the fields
of pharmacy, food, and water. For several years, KIESTRA
has been predominantly active in the field of clinical bacteri-
ology. Jetze Botma is owner and CEO, with a background in
marketing but with a great interest in microbiology and
change management. ‘I am very inspired by changes in medi-
cal bacteriology and feel that in a market sector where auto-
mation and mechanization is only just being introduced we
can improve the medical and economic value of the laborato-
ries so much by developing systems in collaboration with
our innovative customers.’ (See Fig. 1)
Medical bacteriological investigation can be described as hav-
ing just five simple steps. The first step is the inoculation of the
specimen, the second is incubation, the third is reading the
plates, the fourth is identification, and the last is susceptibility
testing. To put this into perspective, there is a need to deter-
mine whether each step has been performed correctly. In a
large number of laboratories, this is done manually. The need is
to determine how well these steps have been performed and
how they can be improved. Thus, looking at inoculation, in 200
laboratories 5–15% of plates do not show single colonies when
spread manually. This can mean a delay of 24 h if replating is
required. However, this can be prevented with the technology
developed by KIESTRA. With incubation, a stable temperature
is required with little loss of moisture. KIESTRA has developed
the slow laminar flow incubator, which maintains an even tem-
perature and reduces the water loss from the plates. Reading of
the plates is often performed in poor surroundings with noise
and disturbance. Doing this in a comfortable and quiet ‘reading
room’ allows a high level of concentration for viewing the digital
images. Identification is performed in most laboratories with
the use of chemical reactions. The matrix-assisted laser desorp-
tion ionization time-of-flight mass spectrometry (MALDI-
TOF MS) technology introduced about 2 years ago by Bruker is
superior to this, and KIESTRA is developing a colony-picking
technology incorporating MALDI-TOF MS to achieve more
accurate and rapid identification. With susceptibility testing,
there are great possibilities regarding the use of digital imaging
for automatic reading and interpretation.
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TLA has been introduced into the blood sciences, and it is
interesting to examine the similarities with and differences
from bacteriology.
In the blood sciences, TLA has been introduced by several
companies, particularly over the past 5 years. These labora-
tories have changed the way in which they work, and have
been able to fit the new system into the same laboratory
space—as have microbiology laboratories. Another similarity
is that more accurate traceability is required. There is also a
lack of competent scientists combined with an increase in
specimen numbers.
Unlike in the blood sciences, where 90% of the specimens
are fluid, bacteriological specimens range from solid to liquid.
This complicates the initial processes. With bacteriology, the
results are much more complex to interpret, and clinical
details are essential. With the blood sciences, there is often
a ‘normal range’, but with bacteriology, each specimen must
be judged individually, and this requires qualified staff. TLA in
bacteriology will support this, not replace human intelligence;
indeed, it will increase the efficiency and knowledge of the
staff, and hence job satisfaction.
Open Architecture
No supplier can offer the complete investigative package, so
customer choice features significantly in purchasing decisions.
There are stand-alone analysers provided by several suppliers
for bulk processing that will deal with single types of specimen.
KIESTRA has an open architecture in its TLA system, the pur-
pose of which is to allow multibranding system integration. KI-
ESTRA’s modular approach allows for stand-alone operation
or total connectivity, giving the laboratory manager greater
choice. Each laboratory manager will decide on the type and
level of automation that are appropriate for their particular
laboratory and situation. However, KIESTRA does not only
focus on the technology. The human factor is most important,
so particular attention is paid to the management of change
through change workshops, covering such topics as implemen-
tation management, ergonomic workbenches, and how to
optimize the work process and workflow. Space is also impor-
tant, but the KIESTRA system, like Lego, can be adjusted to
take on any configuration as dictated by the space available.
The 24/7 Laboratory
Bacteriological diagnosis is continually advancing, particularly
in the areas of proteomics and genomics. Such methodolo-
gies are often developed by small companies wishing to enter
the market, and it is KIESTRA’s philosophy to assist this pro-
cess and incorporate such developments into the KIESTRA
system. An example of this joint approach is the MALDI-
TOF MS technology introduced by Bruker for isolate identifi-
cation. This is being used by many laboratories for identifica-
tion, but there is a need for individual automatic colony
picking. This is where there is a niche for KIESTRA, who,
with Bruker and four Dutch laboratories, is developing a col-
ony-picking system to include this MALDI-TOF MS proteo-
mics technology into its TLA concept. KIESTRA believes that
the MALDI-TOF MS technology is an excellent tool with
which to create a 24/7 non-stop bacteriological identification
and susceptibility system. The technology is economical, as
there are no consumables, and with the KIESTRA system the
plate is transported to the colony picker at the MALDI-
TOF MS bench, who can introduce it into the analyser. With
a rapid result, the colony can be identified as a pathogen and
sensitivity tests can be performed, or as a non-pathogen, in
which case it can be discarded.
To achieve economies of scale, there is a trend towards
larger multidisciplinary laboratory complexes working 24/7.
However, there are still many laboratories serving only one
hospital and the surrounding primary-care doctors. The flexi-
bility of the KIESTRA system, which is modular, allows labo-
ratory managers to choose those modules that are most
appropriate for their situation. So, for example, a small labo-
FIG. 1. Productivity Increase.
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ratory can have a TLA solution by choosing one module of
each type, whereas a bigger laboratory, dealing with large
numbers of specimens, may choose to have several modules
of each type, in order to cope with the throughput. All mod-
ules are linked together by the tracking system to offer the
TLA package—a case of ‘the whole being greater than the
sum of the individual parts’.
Shift work has been long established in blood science lab-
oratories, with some laboratories offering a continuous 24/7
service. Bacteriologists are now being asked to provide the
same level of service. This is seen through extended working
days, with at least one laboratory working three 8-h shifts
over 24 h. The introduction of such patterns of work initially
caused some social disruption, but once they were estab-
lished, evidence suggests that staff adapt and enjoy it. There
are obvious advantages when using the KIESTRA system
over a full 24 h. Investigations can be started as soon as the
specimen is received, and once the incubation period has fin-
ished, further work can be done. This is irrespective of the
time (day or night), resulting in a faster turn-around time for
the specimen (See Fig. 2).
Telebacteriology
Telebacteriology is a spin-off from a technique invented by
the radiologists who use digital technology to record images
for storage and to share them electronically between consul-
tants in different clinics and on different sites. KIESTRA uses
the same technology to record plate images and to develop
the same principle of working. An example of this is how KI-
ESTRA has linked the microbiology department in Ho Chi
Minh City, Vietnam to the Academic Medical Centre,
Amsterdam, to offer e-learning. This makes available a library
of digitally recorded plate images for study by students and
consultants, and offers a rapid method of learning. These
images can also be used in other situations, such as inter-
views for assessing candidates’ knowledge. The other major
benefit of this technology is that plates can be examined any-
time and anywhere, so it is particularly attractive for home-
working. Biomedical scientists can start their day examining
images at home. They can take their children to school, and
then travel to work after the rush hour. Staff at the labora-
tory can work on the plates without the reader being
present. Should the plate itself need to be examined, the
system can retrieve it and present it to the analyst at their
workstation.
Workload Management
The KIESTRA software responsible for running the system
also has the ability to produce management information for
each of its laboratories. This allows them to become more
efficient through the creation of the appropriate match
between skill mix and task to be performed. One of the lab-
oratories has installed the ‘KIESTRA Dashboard’. This is a
120-cm plasma screen that shows, in real time, the workload
status of all specimens in the laboratory. Urgent specimens
can be flagged (e.g. those from intensive-care or high-depen-
dency units), and these can be given priority over routine
specimens. This allows the medical staff to have results as
soon as possible, resulting in a shorter time to treatment for
the patient. The reader technology is also being enhanced
with a neural network, so that earlier detection of suspected
pathogenic growth may be achieved. The plates can then be
automatically sent from the incubator to the MALDI-
TOF MS bench for identification and sensitivity testing. This
could result in a 10–12-h gain in treatment for the patient.
Users of the KIESTRA system have the ability to read
‘patient-centred’ plates rather than those of all one type.
This is especially important for very sick patients. KIESTRA
can not only display all of the current specimen images from
one patient, but it can also show 24-h and 48-h images. This
creates much more confidence in the results, and allows a
high level of consistency. Medical staff can then be given all
the results from one patient at the same time, enhancing
treatment efficiency.
FIG. 2. System Robustness.
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Economical Value
There are significant economic advantages of using TLA.
Customers have shown that they can double or triple their
productivity with TLA. For example, the laboratory produc-
tivity indicator in a manual laboratory processing 24 samples
per full-time equivalent per day can be increased to more
than 60 samples per full-time equivalent per day if KIESTRA’s
philosophy of ‘It’s the sample that moves’ TLA is installed.
This is achieved by reducing the amount of staff movement in
the laboratory, presenting of labelled plates to workers for
inoculation, spreading, and further work, and moving all
plates with the KIESTRA track. Through the creation of a
‘reading room’, and with the use of digital imaging technol-
ogy, plates can be read more quickly, again increasing work-
flow and efficiency. This produces a very ‘lean’ and efficient
laboratory with a comfortable working environment (See Fig.
3).
Laboratory managers and senior staff have noted with
alarm the fall in numbers of students entering bacteriology as
a profession. KIESTRA’s ability to produce a digital image
database using state-of-the-art technology is very appealing
and attractive to students. It facilitates learning through this
unique technology, by allowing the student access to images
not normally available in a routine situation. They also have
the ability to communicate with colleagues all over the world
by sharing images and so vastly increase their knowledge
base. Within the workplace, the availability of an image data-
base as a reference is invaluable and serves several functions.
It can assist with the identification of isolates, be used for
sharing images with colleagues, and be used as a resource
for maintaining professional competence.
KIESTRA Lab Automation is an innovative, highly dedi-
cated organization that continually pushes the boundaries of
bacterial diagnosis. It is highly thought of by its customers,
not only for the high quality of its equipment, but also for its
holistic approach to TLA. It realizes that, for most laborato-
ries, this is a major change in their way of working, so KIES-
TRA becomes part of the change management process,
offering workshops, advice and guidance throughout the
whole period, along with continued support once the system
is in operation.
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FIG. 3. User Satisfaction.
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